Aristo Laboratories Profile
Key Indicators
- Authorised Capital ₹ 9.90 M
as on 24-10-2024
- Paid Up Capital ₹ 9.90 M
as on 24-10-2024
- Company Age 44 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.50 M
as on 24-10-2024
- Revenue 26.19%
(FY 2023)
- Profit -9.66%
(FY 2023)
- Ebitda -11.17%
(FY 2023)
- Net Worth 10.39%
(FY 2023)
- Total Assets 24.91%
(FY 2023)
About Aristo Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.90 M and a paid-up capital of Rs 9.90 M.
The company has closed loans amounting to ₹2.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Umesh Sharma and Virendra Sharma serve as directors at the Company.
- CIN/LLPIN
U24110MH1980PTC266205
- Company No.
266205
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 1980
- Date of AGM
14 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aristo Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Sharma  | Director | 12-Mar-2020 | Current |
| Virendra Sharma | Director | 05-Oct-2006 | Current |
Financial Performance of Aristo Laboratories.
Aristo Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.19% increase. The company also saw a slight decrease in profitability, with a 9.66% decrease in profit. The company's net worth Soared by an impressive increase of 10.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aristo Laboratories?
In 2023, Aristo Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aristo Pharmaceuticals Private LimitedActive 53 years 1 monthUmesh Sharma and Virendra Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Pradesh State Financial Corporation Creation Date: 14 Oct 1992 | ₹2.50 M | Satisfied |
How Many Employees Work at Aristo Laboratories?
Aristo Laboratories has a workforce of 322 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aristo Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aristo Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
